I know there is both a growing interest in – and quite a bit of confusion about – the state of COVID-19 antibody testing. I wanted to take a moment to clear up some of the confusion.

The therapeutic antibody industry has been propelled by ... the details of which are discussed in this focus issue of Nature Reviews Immunology. In their Timeline article, Alain Beck, Thierry ...

A review of recent trends and remaining challenges in bispecific antibody (bsAb) production has been published.

A UK study finds detectable antibodies reduce COVID-19 infection and severity in immunosuppressed individuals, highlighting ...

but the extent of these reviews are still uncertain. New monoclonal antibodies directed against new targets are under development, and hopefully several will emerge as alternative agents in the ...

Highlighted by Genentech's recent US regulatory submission for trastuzumab–DM1, antibody–drug conjugation technology could be heading for the mainstream in anticancer drug development.

The Oncologic Drugs Advisory Committee (ODAC) will review the application based largely ... There has been expectation that the antibody could be made available at a discount to Merck & Co's ...

Antibodies, also known as immunoglobulins (IGs), are glycoproteins produced in response to an immune reaction and exhibit high specificity for the antigens that elicit the response. An antibody ...

The results can inform a doctor if a person has an elevated level of thyroglobulin antibodies, which could indicate autoimmune diseases or cancer. This article reviews the TgAb test, what to ...

The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.